Related by context. Frequent words. (Click for all words.) 63 cardiac muscle contractility 60 Shigamabs ® 60 metastatic liver 59 Ganite R gallium nitrate 58 Shigamabs R 57 cardiac myosin motor 56 mitotic kinesins family 56 Neo Kidney Augment 56 oncolytic virus therapies 55 Phase Ib II 54 photodisinfection 54 Chrysalin 54 commercializing therapeutic 53 anesthetic analgesic 53 ZFP Therapeutics 53 endocrine diseases 53 oncology anti infective 53 therapeutic monoclonal antibodies 52 topical anti infective 52 Earth orbit geosynchronous 52 CTLM ® 52 Biodefense Division 52 siRNA therapeutics 52 peptide therapeutics 52 polymeric formulations 52 Ketotransdel 52 drug eluting coronary stent 52 ZEGERID R 52 GVAX R 52 cardiovascular metabolic 51 areas oncology endocrinology 51 GVAX cancer 51 CMV vaccine 51 oncology infectious diseases 51 cognitive impairment associated 51 Testim R 51 Med eMonitor System 50 bio therapeutics 50 Ligand proprietary 50 glucose sensing 50 opioid induced bowel dysfunction 50 Tissue Repair Company 50 drug eluting stent DES 50 novel antibody therapeutics 50 AutovaxID 50 NCCN initiatives 50 autoimmune inflammatory 49 Enzo Therapeutics 49 online pharmacy CVS.com 49 initiate Phase IIb 49 outlicense 49 immunologic diseases 49 peripherally acting 49 Group Mineral PGM 49 specialty biopharmaceutical 49 West Cedartree gold 49 Atrigel 49 InnerCool Therapies 49 system vaporizes unformulated 49 Jarden operates 49 advancing novel biotherapeutics 49 prenatal diagnostics 49 inflammatory autoimmune 48 coupled receptor GPCR 48 atrial fibrillation cardiac 48 Lipid Polymer Micelle LPM 48 infill submarkets 48 Fibrillex TM 48 cervical breast 48 orthobiologic 48 factor VIIa 48 staphylococcal vaccines 48 symptomatic uterine fibroids 48 biodefense vaccines 48 human antibody therapeutics 48 transmucosal film 48 refractory angina 48 hospitalist medicine 48 immunotherapeutics 47 Currently RegeneRx 47 multivalency toward drug 47 Alzheimer disease epilepsy 47 PEGylation technology 47 Aurcana Corporation 47 OGeS 47 pharmacodynamic effects 47 concerning CombinatoRx 47 Humanitarian Device Exemption 47 health diagnostics GYN 47 gynecologic procedures 47 RAM Reinsurance 47 thedevelopment 47 leading lipid nanoparticle 47 DigiScope 47 Attracting Bullish Investors 47 novel immunosuppressive therapeutics 47 oncology cardiology 47 Whabouchi 46 Corporation Nasdaq UAUA 46 antibody therapies 46 theranostics